Funding for this research was provided by:
Merck KGaA (N/A)
Received: 8 January 2020
Accepted: 10 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: Treatment with the easypod™/easypod™ connect platform was conducted according to local practice. This real-world, observational, retrospective analysis of the dataset was performed in accordance with the informed consent form, signed by caregivers of children and adult patients materializing their agreement for data collection, storage and use of their pseudonymized data to create aggregated statistical and general adherence reports.
: Not applicable.
: VT is an employee of Ares Trading, an affiliate of Merck KGaA, Darmstadt Germany. EK is an employee of Merck KGaA, Darmstadt, Germany. PvD has a consultancy agreement with Merck KGaA, Darmstadt, Germany.